Infective endocarditis (IE) is an important clinical disease in children with a mortality rate of 11.6%. Prophylaxis with antibiotics is one of the most commonly used methods in children at risk of IE; therefore, the evaluation of antibiotic resistance seems necessary in view of its increasing trend. This study aimed to determine the antibiotic susceptibility pattern of oral viridans group streptococci (VGS) isolated from the dental plaque of children at risk of IE. Fifty-one plaque samples were obtained from children aged 3 to 12 years old in the period from April to July 2018. Samples were obtained with sterile swabs and were transferred to the laboratory in Brain Heart Infusion (BHI) Broth. Samples were immediately cultivated on Columbia blood agar. After identifying VGS, antimicrobial susceptibility test (AST) was performed using Mueller-Hinton agar (MHA) with sheep's blood and E-test strips for selected antibiotics. The minimum inhibitory concentration (MIC) was determined for each isolate and the results were reported as sensitive, intermediate and resistant. Fifty-one VGS bacteria were isolated from children with an average age of 7.3 ± 2.5 years. The highest resistance was observed for azithromycin in 36 (70.6%) isolates and then cefazolin in 35 (68.6%) isolates. The highest susceptibility was observed for amoxicillin in 46 (90.2%) isolates. Based on the findings of this study, amoxicillin is the most effective option for prophylaxis in children. Furthermore, cefazolin should be used with caution because bacteria resistant to this antibiotic can transfer resistance genes to other bacteria.
References
1.
Aslam B, Wang W, Arshad MI, Khurshid M, Muzammil S, Rasool MH, et al. Antibiotic resistance: a rundown of a global crisis. Infection and Drug Resistance. Volume 11:1645–58.
2.
Liu S, Zheng Y, Wu X, Xu B, Liu X, Feng G, et al. Early target attainment of azithromycin therapy in children with lower respiratory tract infections. Journal of Antimicrobial Chemotherapy. 2018;73(10):2846–50.
3.
M.J S. Acute Lower Respiratory Tract Infections Including Pneumonia; Clinical Approach to Diagnosis and Treatment: A Narrative Review. J Clin Exc. 2014;3(1):29–45.
4.
Malhotra-Kumar S, Lammens C, Coenen S, Van Herck K, Goossens H. Effect of azithromycin and clarithromycin therapy on pharyngeal carriage of macrolide-resistant streptococci in healthy volunteers: a randomised, double-blind, placebo-controlled study. The Lancet. 2007;369(9560):482–90.
5.
Dhotre S, Jahagirdar V, Suryawanshi N, Davane M, Patil R, Nagoba B. Assessment of periodontitis and its role in viridans streptococcal bacteremia and infective endocarditis. Indian Heart Journal. 2018;70(2):225–32.
6.
Borji A, Naghavi A, Borji H. An investigation on drug resistance of viridance group streptococci isolated from 3-12 years healthy individuals. Zahedan J Res Med Sci. 2010;12(4):28–32.
7.
Fani M, Kohanteb J, Dayaghi M. Inhibitory activity of garlic (Allium sativum) extract on multidrug-resistant Streptococcus mutans. Journal of Indian Society of Pedodontics and Preventive Dentistry. 2007;25(4):164.
8.
Geethu M, Prabhu N, Jasmine M. Antimicrobial susceptibility trends among viridan streptococci isolates from cases of endocarditis from 2007-2009. Ann Biol Res. 2010;1(1):130–3.
9.
F.C G, F.M C, A.B P. Antimicrobial resistance of Staphylococcus aureus and oral streptococci strains from high-risk endocarditis patients. Gen Dent. 2005;53(6):410–3.
10.
Karikalan S, Mohankumar A. Studies on ampicillin resistant plasmid of Streptococcus mutans isolated from dental caries patients. Bioscience Biotechnology Research Communications. 2016;9(1):151–6.
11.
Basak S, Singh P, Rajurkar M. Multidrug Resistant and Extensively Drug Resistant Bacteria: A Study. Journal of Pathogens. 2016;2016:1–5.
12.
Chunduri N, Madasu K, Goteki V, Karpe T, Reddy H. Evaluation of bacterial spectrum of orofacial infections and their antibiotic susceptibility. Annals of Maxillofacial Surgery. 2012;2(1):46.
13.
William B, Rwenyonyi CM, Swedberg G, Kironde F. Cotrimoxazole Prophylaxis Specifically Selects for Cotrimoxazole Resistance inStreptococcus mutansandStreptococcus sobrinuswith Varied Polymorphisms in the Target GenesfolAandfolP. International Journal of Microbiology. 2012;2012:1–10.
14.
Hussain Z, Curtain C, Mirkazemi C, Gadd K, Peterson GM, Zaidi STR. Prophylactic Cefazolin Dosing and Surgical Site Infections: Does the Dose Matter in Obese Patients? Obesity Surgery. 2019;29(1):159–65.
15.
Kim MK, Chuang SK, August M. Antibiotic Resistance in Severe Orofacial Infections. Journal of Oral and Maxillofacial Surgery. 2017;75(5):962–8.
16.
Ang JY, Asmar BI. Multidrug-Resistant Viridans Streptococcus (MDRVS) Osteomyelitis of the Mandible Successfully Treated with Moxifloxacin. Southern Medical Journal. 2008;101(5):539–40.
17.
Nagoba B, Dhotre S, Dharne M, Potdar S, Suklikar J, Suryawanshi N. Viridians Group Streptococci in Patients Undergoing Tooth Extraction. Electronic Journal of General Medicine. 2015;12(3).
18.
Cahill TJ, Harrison JL, Jewell P, Onakpoya I, Chambers JB, Dayer M, et al. Antibiotic prophylaxis for infective endocarditis: a systematic review and meta-analysis. Heart. 2017;103(12):937–44.
19.
Vogkou CT, Vlachogiannis NI, Palaiodimos L, Kousoulis AA. The causative agents in infective endocarditis: a systematic review comprising 33,214 cases. European Journal of Clinical Microbiology & Infectious Diseases. 2016;35(8):1227–45.
20.
Błochowiak KJ. Dental treatment and recommended management in patients at risk of infective endocarditis. Polish Journal of Cardio-Thoracic Surgery. 2019;16(1):37–41.
21.
Chitra N, Mangayarkarasi V, Balakrishnan D, A.S SG. Resistance Patterns of Viridans Group of Streptococci isolated in transient bacteremia after third molar surgery. Int J Curr Microbiol App Sci. 2015;4(6):78–85.
Süzük S, Kaşkatepe B, Çetin M. Antimicrobial susceptibility against penicillin, ampicillin and vancomycin of viridans group Streptococcus in oral microbiota of patients at risk of infective endocarditis. Infez Med. 2016;24(3):190–3.
24.
Goldsmith CE, Hara Y, Sato T, Nakajima T, Nakanishi S, Mason C, et al. Comparison of antibiotic susceptibility in viridans group streptococci in low and high antibiotic-prescribing General Practices. Journal of Clinical Pharmacy and Therapeutics. 2015;40(2):204–7.
25.
Poveda-Roda R, Jiménez Y, Carbonell E. Bacteremia originating in the oral cavity: A review. Med Oral Patol Oral Cir Bucal. 2008;13(6).
26.
Kelchtermans J, Grossar L, Eyskens B, Cools B, Roggen M, Boshoff D, et al. Clinical Characteristics of Infective Endocarditis in Children. Pediatric Infectious Disease Journal. 2019;38(5):453–8.
27.
Dixon G, Christov G. Infective endocarditis in children: an update. Current Opinion in Infectious Diseases. 2017;30(3):257–67.
28.
Seymour RA. Dentistry and the medically compromised patient. The Surgeon. 2003;1(4):207–14.
29.
Thornhill MH, Dayer M, Lockhart PB, Prendergast B. Antibiotic Prophylaxis of Infective Endocarditis. Current Infectious Disease Reports. 2017;19(2).
30.
Abu-zineh R, Dar-Odeh N, Shehabi A. Macrolide resistance genes and virulence factors of common viridans Streptococci species colonizing oral cavities of patients in Jordan. Oral Health Dent Manag. 2015;14:337–41.
31.
Nemoto H, Nomura R, Ooshima T, Nakano K. Distribution of amoxicillin-resistant oral streptococci in dental plaque specimens obtained from Japanese children and adolescents at risk for infective endocarditis. Journal of Cardiology. 2013;62(5):296–300.
32.
Parks T, Barrett L, Jones N. Invasive streptococcal disease: a review for clinicians. British Medical Bulletin. 2015;115(1):77–89.
33.
Prakash D, Ramesh K, Gopinath N. Antibacterial efficacy of Syzygium aromaticum extracts on multi-drug resistant Streptococcus mutans isolated from dental plaque samples. J Biochem Technol. 2014;3(5):155–7.
34.
Rotimi VO, Salako NO, Mokaddas E, Philip L, Rajan P. High Frequency of Isolation of Antibiotic-Resistant Oral Viridans Streptococci from Children in Kuwait. Journal of Chemotherapy. 2005;17(5):493–501.
35.
Chun S, Huh HJ, Lee NY. Species-Specific Difference in Antimicrobial Susceptibility Among Viridans Group Streptococci. Annals of Laboratory Medicine. 2015;35(2):205–11.
36.
Park SC, Park Y, Hahm KS. The Role of Antimicrobial Peptides in Preventing Multidrug-Resistant Bacterial Infections and Biofilm Formation. International Journal of Molecular Sciences. 12(9):5971–92.
37.
Garg P, Ko DT, Bray Jenkyn KM, Li L, Shariff SZ. Infective Endocarditis Hospitalizations and Antibiotic Prophylaxis Rates Before and After the 2007 American Heart Association Guideline Revision. Circulation. 2019;140(3):170–80.
38.
Shafiee F, Moghadamnia AA, Shahandeh Z, Sadighian F, Khodadadi E. Evaluation of the antibacterial effects of aqueous and ethanolic leaf extracts of Aloysia Citriodora (Lemon verbena) on Streptococcus mutans and Streptococcus sobrinus. Electronic physician. 8(12):3363–8.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
